Selwyn Ho

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Selwyn Ho
Sep 29, 2024, 13:56 | Blog
Medigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021
Medigene AG, an oncology platform company focused on the research and development of T cell…
Sep 7, 2024, 14:50 | Blog
Medigene Announces U.S. FDA Clearance of IND Application for MDG1015 for Multiple Solid Tumor Indications
Medigene AG, an oncology platform company focused on the research and development of T cell…
Aug 23, 2024, 16:10 | Blog
Medigene AG Reports Half-Year 2024 Financial Results and Provides Corporate Update
Medigene AG, an oncology platform company focused on the research and development of T cell…
Aug 13, 2024, 07:26 | Blog
Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T-Cell Engagers
Medigene AG and WuXi Biologics enter into a three-year, multi-target strategic partnership to design and co-research…
Jul 7, 2024, 07:08 | Insight
Medigene AG Expands Patent Portfolio with the Patent Grant for NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell…
Jul 1, 2024, 09:17 | Blog
Medigene Reports Results of Annual General Meeting
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell…
Jun 2, 2024, 22:26 | Blog
Medigene AG Expands its End-to-End Platform by Submitting Three Patents to the European Patent Office
Medigene AG an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies…
May 23, 2024, 07:44 | Blog
Medigene's Global Research and Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term
Medigene AG an immuno-oncology platform company focusing on the discovery and development of differentiated T cell…
May 16, 2024, 08:20 | Blog
Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise Cash runway…
All: 9 Posts: 1 - 100
Special Coverage